Ureaplasma is treated with antibiotics, most commonly doxycycline or azithromycin as first-line options. The specific antibiotic your provider chooses depends on factors like pregnancy status, whether you’ve already tried a course that didn’t work, and local resistance patterns. Most people notice symptom relief within several days of starting an effective antibiotic, and a full course typically lasts 7 to 14 days.
First-Line Antibiotics
Doxycycline is the most widely prescribed treatment for ureaplasma infections. The standard course is 100 mg taken twice daily for 7 days, though some providers extend this to 10 or 14 days depending on the severity or location of the infection. In case reports, patients treated with doxycycline for 10 days experienced complete resolution of symptoms. Azithromycin is also effective and sometimes preferred for its simpler dosing schedule, often given as a short course.
Resistance rates to both of these antibiotics remain low globally. A large surveillance study covering six years of data in Eastern China found that fewer than 3% of ureaplasma samples were resistant to azithromycin, and resistance to doxycycline stayed below 1%. That means the vast majority of infections will clear with one of these standard treatments.
When First-Line Treatment Fails
If symptoms persist after a full course of doxycycline or azithromycin, moxifloxacin is the typical next step. It belongs to a different class of antibiotics (fluoroquinolones) and works through a separate mechanism, making it effective against strains that resist other drugs. A common approach is to take doxycycline for 7 days first, then follow with moxifloxacin at 400 mg daily for another 7 days. If symptoms still haven’t resolved, that moxifloxacin course may be extended to 14 days.
Minocycline is another option in the same family as doxycycline. Clinical trials comparing the two found no significant difference in cure rates for urethritis and cervicitis. Minocycline may be tried when doxycycline hasn’t worked, though because they’re closely related drugs, it’s not always a dramatic improvement. Your provider may skip to moxifloxacin instead if they suspect true tetracycline resistance.
Treatment During Pregnancy
Pregnancy significantly narrows the available options. Doxycycline and other tetracyclines are not safe during pregnancy, and fluoroquinolones like moxifloxacin are also avoided. That leaves macrolide antibiotics, particularly erythromycin, as the primary choice. Erythromycin is active against ureaplasma and has an established safety profile in pregnancy.
One large trial involving over 1,000 pregnant women tested erythromycin and clindamycin against a placebo in women colonized with ureaplasma between 22 and 32 weeks of gestation. Side effects serious enough to stop treatment were not significantly different between the antibiotic and placebo groups. However, the evidence is still limited on whether treating ureaplasma during pregnancy actually prevents complications like preterm birth. The decision to treat typically depends on whether you’re experiencing active symptoms or have other risk factors your provider is monitoring.
Treatment for Newborns
Ureaplasma can be transmitted to newborns during delivery and is a concern in premature infants, where it’s linked to lung complications. In neonatal intensive care settings, azithromycin given intravenously is the primary treatment. A review of multiple clinical studies found that a dose of 20 mg/kg given once daily for 3 days was the most effective protocol for clearing the infection in newborns. Treatment decisions for infants are made by the care team based on the baby’s weight, gestational age, and clinical status.
Why Your Partner Needs Treatment Too
Ureaplasma is sexually transmitted, and reinfection from an untreated partner is one of the most common reasons people don’t get better. European guidelines for urethritis management are clear on this point: current sexual partners should be tested and treated, and you should avoid sexual contact until both of you have completed the full antibiotic course. There are documented cases of patients with persistent, recurring ureaplasma-positive infections who only cleared the infection after their partner received appropriate treatment.
If your partner has no symptoms, they still need to be evaluated. Ureaplasma can colonize the genital tract without causing obvious symptoms, meaning your partner can carry and pass it back to you even while feeling fine.
How Long Symptoms Take to Improve
Most people start feeling better within the first few days of an effective antibiotic. Common symptoms like burning during urination, unusual discharge, or pelvic discomfort typically begin to ease before you’ve finished the full course. That said, finishing all prescribed doses is essential even if you feel better early. Stopping short increases the risk of incomplete clearance and potential resistance.
After completing treatment, you should wait at least 3 weeks before doing a follow-up test to confirm the infection is gone. Testing too early can pick up residual genetic material from dead bacteria and produce a false positive, making it look like treatment failed when it actually worked. This 3-week window applies to nucleic acid tests (the type most commonly used for ureaplasma). If you’re still having symptoms at that point and the test comes back positive, your provider will likely move to a second-line antibiotic or investigate whether reinfection from a partner is the issue.
Putting a Treatment Plan Together
For most people, ureaplasma treatment follows a straightforward path: a week of doxycycline, partner treatment at the same time, abstaining from sex during the course, and a follow-up test three weeks later. The cure rate with this approach is high given the consistently low resistance rates seen in surveillance data.
Where things get more complicated is in cases of persistent infection, pregnancy, or when ureaplasma is found alongside other organisms like mycoplasma. In those situations, treatment may involve sequential antibiotics (one drug followed by another), longer courses, or pregnancy-safe alternatives. The key variables your provider will weigh are which antibiotic you can safely take, whether your partner has also been treated, and whether a previous course has already failed.